BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Leukemia
NCI Information
Clinical Trials
Leukemia Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Leukemia Podcasts and Videos
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201204039
Principal Investigator:
Schroeder, Mark
Title:
Expanded Access Program of Ponatinib (AP24534) for Patients with Refractory Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia
Phase:
N/A
Disease Site:
Myeloid and Monocytic Leukemia
Participating Site(s):
Main Campus
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to give patient's with Chronic Myeloid Leukemia (CML) or Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ ALL) access to an experimental drug called ponatinib because other standard treatments haven’t worked or are no longer working for treatment of their leukemia. Ponatinib is being studied as a possible cancer treatment for CML and Ph+ ALL.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)